UBS: Maintains "buy" rating on PCCW (00008) and raises target price to 5.5 Hong Kong dollars.
This line lowers Hutchison Telecommunications' revenue and EBITDA forecasts from 2021 to 2027 by 0% to 6%, lowers the dividend per share forecast by 1% to 5%, and expects the dividend per share to remain flat.
UBS releases research report, maintaining a "buy" rating on PCCW (00008), with a target price raised from 5 Hong Kong dollars to 5.5 Hong Kong dollars, and a dividend yield of 7.8 cents. The company's revenue in the second half of last year increased by 2% year-on-year to 19.9 billion Hong Kong dollars, while EBITDA remained flat year-on-year at 7.2 billion Hong Kong dollars, lower than expected mainly due to increased expenses from the expansion of the media business. The company announced a final dividend per share of 0.2848 Hong Kong dollars, unchanged from last year, equivalent to 95% of HKT-SS (06823) annual dividend.
The bank has lowered its revenue and EBITDA forecasts for PCCW from 2021 to 2027 by 6%, reduced dividend per share forecast by 1% to 5%, expecting dividends per share to remain flat instead of maintaining the stable dividend payout ratio of Hong Kong Telecom, to support the media and solutions business that may still be burning cash.
Related Articles

New stock news: Beijing GeoEnviron Engineering & Technology, Inc. (603588.SH) has submitted documents to the Hong Kong Stock Exchange.

New stock news | China Resources Pharmaceutical Group submits its listing application to the Hong Kong Stock Exchange again.

New stock news | Oral care brand "Canban" parent company Xiaokuo Group submitted an application to the Hong Kong Stock Exchange.
New stock news: Beijing GeoEnviron Engineering & Technology, Inc. (603588.SH) has submitted documents to the Hong Kong Stock Exchange.

New stock news | China Resources Pharmaceutical Group submits its listing application to the Hong Kong Stock Exchange again.

New stock news | Oral care brand "Canban" parent company Xiaokuo Group submitted an application to the Hong Kong Stock Exchange.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


